期刊文献+

羊水间期细胞荧光原位杂交检测残余风险评估:6125例产前细胞遗传学诊断回顾性分析 被引量:7

Evaluation of residual risk of cytogenetic abnormalities after prenatal diagnosis by interphase fluorescence in situ hybridization in second-trimester:a retrospective analysis of conventional karyotyping on 6125 consecutive amniotic fluid specimens
下载PDF
导出
摘要 目的评估中孕期羊水间期细胞荧光原位杂交(FISH)检测之后漏诊非13、18、21、X、Y染色体的非整倍体异常核型的残余风险,从产前咨询的角度来评价间期FISH检测在产前诊断中的作用。方法对6 125例中孕期羊水传统核型分析的结果进行回顾性分析,假设这些病例均进行间期FISH检测,计算在三大产前诊断指征(孕妇高龄、孕母血清学筛查18-三体或21-三体高风险、妊娠23周前超声发现胎儿有结构异常)情况下间期FISH检测的检出率以及残余风险。结果从2011年1月至2014年9月共有6 125例单胎孕妇行中孕期羊水细胞核型分析,共检出207例(3.38%)异常核型。有161例(77.8%)为涉及13、18、21、X、Y染色体非整倍体的异常核型(包括嵌合体),其间期FISH检测结果为阳性。有46例(22.2%)异常结果是非13、18、21、X、Y染色体的非整倍体,其中包括平衡性结构重排31例(67.4%)、非平衡性结构重排14例(30.4%)、其他染色体非整倍体1例(2.2%)。在这46例异常核型中,有6例涉及21号染色体和1例涉及13号染色体的不平衡性重排的间期FISH检测结果为阳性,其余39例间期FISH检测结果均为阴性。计算间期FISH检测的检出率为81.2%(168/207),间期FISH检测的残余风险为0.65%(39/5957)。结论间期FISH检测是核型分析的有效补充,但不能取代核型,单纯行间期FISH检测进行产前诊断会漏诊约18.8%的染色体异常。在产前遗传咨询时应向病人解释间期FISH的检出率和残余风险,了解间期FISH的优点和局限性,帮助其选择合适的产前诊断手段。 Objective: To analyze the results from conventional cytogenetic studies of second-trimester amniocytes and determine the residual risk for a cytogenetic abnormality if interphase fluorescence in situ hybridization(FISH),capable of only detecting aneuploidies for chromosome 13,18,21,X,Y was performed and did not reveal an abnormality.Methods:Results from conventional karyotyping on 6 125 consecutive amniotic fluid specimens were analyzed retrospectively.Detection rate and residual risk of interphase FISH were calculated for the three major clinical indications for prenatal diagnosis(advanced maternal age,abnormal maternal serum screening indicating increased risks for trisomy 18 or trisomy 21,ultrasound abnormality).Results: A total of 6 125 consecutive karyotyping on second-trimester amniocytes for prenataldiagnosis were performed from January 2011 to Spetember 2014.Two hundreds and seven(3.38%)cases of abnormal karyotypes were found,including 161 cases of aneuploidies involving chromosome 13,18,21,X and Y,which were considered detectable by interphase FISH.Forty six cases of chromosomal anomalies other than the aneuploidies of chromosome 13,18,21,X and Y were diagnosed after karyotyping and not detected by interphase FISH,including 31 cases of balanced rearrangements,14 cases of imbalanced rearrangenents,1case of pseudomosaic of trisomy 20.Among the 46 cases of chromosomal anomalies,6cases of imbalanced rearrangements involving chromosome 21 and 1case of imbalanced rearrangement involving chromosome 13 showed positive FISH results,and the other 39 cases showed negative FISH results,with a total detection rate of interphase FISH of 81.2%(168/207)and a residual risk of 0.65%(39/5957)following the interpahse FISH on second-trimester amniocytes.Conclusions:Interphase FISH is a useful adjunct to conventional karyotyping,but should not be considered as a replacement for karyotyping as too many structural chromosomal abnormalities will be missed.Providing patients with detection rate and residual risk during counselling could help them understand the advantages and limitations of interphase FISH in their prenatal diagnostic evaluation.
出处 《生殖医学杂志》 CAS 2015年第6期429-435,共7页 Journal of Reproductive Medicine
关键词 间期FISH 产前诊断 染色体异常 检出率 残余风险 回顾性分析 Interphase FISH Prenatal diagnosis Chromosomal abnormalities Detection rate Residual risk Retrospective analysis
  • 相关文献

参考文献17

  • 1Caine A,Maltby AE,Parkin CA,et al.Prenatal detection of Down’s syndrome by rapid aneuploidy testing for chromosomes13,18,and 21 by FISH or PCR without a full karyotype:a cytogenetic risk assessment[J].Lancet,2005,9480:123-128.
  • 2Evans MI,Henry GP,Miller WA,et al.International,collaborative assessment of 146,000 prenatal karyotypes:expected limitations if only chromosome-specific probes and fluorescent in-situ hybridization are used[J].Hum Reprod,1999,5:1213-1216.
  • 3Pergament E,Chen PX,Thangavelu M,et al.The clinical application of interphase FISH in prenatal diagnosis[J].Prenat Diagn,2000,3:215-220.
  • 4Tepperberg J,Pettenati MJ,Rao PN,et al.Prenatal diagnosis using interphase fluorescence in situ hybridization(FISH):2-year multi-center retrospective study and review of the literature[J].Prenat Diagn,2001,4:293-301.
  • 5Thilaganathan B,Sairam S,Ballard T,et al.Effectiveness of prenatal chromosomal analysis using multicolor fluorescent in situ hybridisation[J].BJOG,2000,2:262-266.
  • 6Thein AT,Abdel-Fattah SA,Kyle PM,et al.An assessment of the use of interphase FISH with chromosome specific probes as an alternative to cytogenetics in prenatal diagnosis[J].Prenat Diagn,2000,4:275-280.
  • 7Qi Q,Zhou X,Jiang Y,et al.A rare de novo duplication of chromosome 21q22.12-->q22.3 with other concomitant deletion and duplication of small fragments in 21q associated with Down syndrome:prenatal diagnosis,molecular cytogenetic characterization[J].Mol Cytogenet,2013,6(1):11.doi:10.1186/1755-8166-6-11.
  • 8戚庆炜,郝娜,周京,刘俊涛,边旭明.妊娠中期产前诊断羊水20-三体假性嵌合体一例[J].中华围产医学杂志,2014,17(12):822-825. 被引量:8
  • 9Hulten MA,Dhanjal S,Pertl B.Rapid and simple prenatal diagnosis of common chromosome disorders:advantages and disadvantages of the molecular methods FISH and QF-PCR[J].Reproduction,2003,3:279-297.
  • 10Homer J,Bhatt S,Huang B,et al.Residual risk forcytogenetic abnormalities after prenatal diagnosis by interphase fluorescence in situ hybridization(FISH)[J].Prenat Diagn,2003,7:566-571.

二级参考文献15

  • 1Hsu LY, Perlis TE. United States survey on chromosomemosaicism and pseudomosaicism in prenatal diagnosis[J].Prenat Diagn, 1984, 4 Spec No:97_130.
  • 2Bui TH, Iselius L, Lindsten J. European collaborative study onprenatal diagnosis: mosaicism, pseudomosaicism and singleabnormal cells in amniotic fluid cell cultures[J]. Prenat Diagn,1984, 4 Spec No:145-162.
  • 3Worton RG, Stern R. A Canadian collaborative study ofmosaicism in amniotic fluid cell cultures[J]. Prenat Diagn,1984,4 Spec No:131- 144.
  • 4Hsu LY, Benn PA. Revised guidelines for the diagnosis ofmosaicism in amniocytes[J]. Prenat Diagn, 1999,19:1081-1082.
  • 5Tepperberg J, Pettenati MJ, Rao PN, et al. Prenatal diagnosisusing interphase fluorescence in situ hybridization ( FISH ):2-year multi-center retrospective study and review of theliterature[J]. Prenat Diagn, 2001,21:293-301.
  • 6Hsu LY, Kaffe S, Perlis TE. Trisomy 20 mosaicism in prenataldiagnosis: a review and update[J]. Prenat Diagn, 1987,7:581-596.
  • 7Hassold T, Abruzzo M, Adkins K, et al. Human aneuploidy:incidence, origin, and etiology[J]. Environ Mol Mutagen, 1996,28:167-175.
  • 8James PA, Gibson K, McGaughran J. Prenatal diagnosis ofmosaic trisomy 20 in New Zealand[J]. Aust N Z J ObstetGynaecol, 2002,42:486-489.
  • 9Wallerstein R, Yu MT, Neu RL, et al. Common trisomymosaicism diagnosed in amniocytes involving chromosomes13,18,20 and 21: karyotype-phenotype correlations[J]. PrenatDiagn, 2000,20:103-122.
  • 10Steinberg Warren N, Soukup S, King JL, et al. Prenataldiagnosis of trisomy 20 by chorionic villus sampling ( CVS ):a case report with long-term outcome[J]. Prenat Diagn, 2001,21:1111-1113.

共引文献7

同被引文献45

  • 1American College of Medical Genetics. Prenatal interphase fluorescence in situ hybridization (FISH) policy statement[J]. Am J Hum Genet, 1993,53(2):526-527.
  • 2Technical and clinical assessment of fluorescence in situ hybridization: an ACMG/ASHG position statement. I. Technical considerations. Test and Technology Transfer Committee[J]. Genet Med, 2000,2(6):356-361.
  • 3American College of Medical Genetics and Genomics. Standards and guidelines for clinical genetics laboratories, Section E: clincal cytogenetics-2011[EB/OL]. [2016-01-25]. https://www.aemg.net/StaticContent/SGs/Section_E_2011 .pdf.
  • 4Schwartz S. Preparation of Amniocytes for Interphase Fluorescence In Situ Hybridization (FISH)[J]. Curr Protoc Hum Genet, 2015,85:8.9.1-8.9.16. DOI: 10.1002/0471142905. hgO809s85.
  • 5Sparkes R, Johnson JA, Langlois S, et al. New molecular techniques for the prenatal detection of chromosomal aneuploidy[J]. J Obstet Gynaecol Can, 2008,30(7):617-627.
  • 6Sheets KB, Crissman BG, Feist CD, et al. Practice guidelines for communicating a prenatal or postnatal diagnosis of Down syndrome: recommendations of the national society of genetic counselors[J]. J Genet Couns, 2011,20(5):432-441. DOI: 10.1007/s10897-011-9375-8.
  • 7Hong Kong College of Obstetricians and Gynaeeologists.HKCOG Guidelines Number 4 (revised November 2009): Guidelines for amniocentesis and chorionic villus sampling (CVS) [EB/OL]. [2016-01-25]. http://www.hkcog.org.hk/hkcog/ Download/Guidelines_for_Amniocentesis and Chorionic_Vi- llus_Sampling_2009.pdf.
  • 8Nagan N, Faulkner NE, Curtis C, et al. Laboratory guidelines for detection, interpretation, and reporting of maternal cellcontamination in prenatal analyses a report of the association for molecular pathology[J]. J Mol Diagn, 2011, 13(1):7-11. DOI: 10.1016/j.jmoldx.2010.11.013.
  • 9Shaffer LG, McGowan-Jordan J, Schmid M. ISCN 2013: an international system for human cytogenetic nomenclature (2013)[M]. Basel: Karger, 2013:105-120.
  • 10戚庆炜,蒋宇林,刘俊涛,边旭明,李岩,吕时铭,朱宝生,王和,许争锋,潘小英,蔡艳.对高龄孕妇于孕中期行血清学二联指标筛查胎儿唐氏综合征的多中心前瞻性研究[J].中华妇产科杂志,2008,43(10):737-741. 被引量:69

引证文献7

二级引证文献86

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部